tiprankstipranks
Trending News
More News >
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market

ADC Therapeutics (ADCT) Financial Statements

Compare
407 Followers

ADC Therapeutics Financial Overview

ADC Therapeutics's market cap is currently $473.21M. The company's EPS TTM is $-0.3; its P/E ratio is -2.55; ADC Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 70.84M$ 69.56M$ 209.91M$ 33.92M$ 0.00
Gross Profit$ 64.89M$ 67.03M$ 206.61M$ 32.52M$ -141.82M
Operating Income$ -130.65M$ -165.99M$ -123.34M$ -261.72M$ -219.26M
EBITDA$ -102.65M$ -145.83M$ -107.70M$ -230.53M$ -218.23M
Net Income$ -157.85M$ -240.05M$ -157.13M$ -230.03M$ -246.29M
Balance Sheet
Cash & Short-Term Investments$ 250.87M$ 278.60M$ 326.44M$ 466.54M$ 439.19M
Total Assets$ 321.98M$ 354.78M$ 490.86M$ 617.97M$ 513.69M
Total Debt$ 123.00M$ 124.38M$ 129.85M$ 139.70M$ 115.08M
Net Debt$ -127.87M$ -154.22M$ -196.59M$ -326.85M$ -324.11M
Total Liabilities$ 524.62M$ 503.03M$ 411.41M$ 451.88M$ 178.19M
Stockholders' Equity$ -202.64M$ -148.25M$ 79.45M$ 166.09M$ 335.50M
Cash Flow
Free Cash Flow$ -124.70M$ -121.90M$ -139.00M$ -239.75M$ -171.54M
Operating Cash Flow$ -123.83M$ -118.69M$ -138.31M$ -233.38M$ -168.73M
Investing Cash Flow$ -867.00K$ -3.22M$ -687.00K$ -6.67M$ -2.83M
Financing Cash Flow$ 97.05M$ 73.88M$ -897.00K$ 267.39M$ 494.97M
Currency in USD

ADC Therapeutics Earnings and Revenue History

ADC Therapeutics Debt to Assets

ADC Therapeutics Cash Flow

ADC Therapeutics Forecast EPS vs Actual EPS